Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05579366
Title Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/PRO1184-001) (PRO1184-001)
Acronym PRO1184-001
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ProfoundBio US Co.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.